Douglas D - Search Results

1

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.

Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD. Blick C, et al. Among authors: douglas d. Cancer. 2012 Aug 15;118(16):3920-7. doi: 10.1002/cncr.26675. Epub 2012 Jan 3. Cancer. 2012. PMID: 22614698 Free article.

2

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.

Gowardhan B, Douglas DA, Mathers ME, McKie AB, McCracken SR, Robson CN, Leung HY. Gowardhan B, et al. Among authors: douglas da. Br J Cancer. 2005 Jan 31;92(2):320-7. doi: 10.1038/sj.bjc.6602274. Br J Cancer. 2005. PMID: 15655558 Free PMC article.

3

Current drug therapy for prostate cancer: an overview.

Stewart AB, Lwaleed BA, Douglas DA, Birch BR. Stewart AB, et al. Curr Med Chem Anticancer Agents. 2005 Nov;5(6):603-12. doi: 10.2174/156801105774574658. Curr Med Chem Anticancer Agents. 2005. PMID: 16305482 Review.

4

Contemporary practice and technique-related outcomes for radical prostatectomy in the UK: a report of national outcomes.

Laird A, Fowler S, Good DW, Stewart GD, Srinivasan V, Cahill D, Brewster SF, McNeill SA; British Association of Urological Surgeons (BAUS). Laird A, et al. BJU Int. 2015 May;115(5):753-63. doi: 10.1111/bju.12866. Epub 2014 Oct 22. BJU Int. 2015. PMID: 25046349

5

Fibroblast growth factor 17 is over-expressed in human prostate cancer.

Heer R, Douglas D, Mathers ME, Robson CN, Leung HY. Heer R, et al. Among authors: douglas d. J Pathol. 2004 Dec;204(5):578-86. doi: 10.1002/path.1668. J Pathol. 2004. PMID: 15538740

6

Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer.

McKie AB, Douglas DA, Olijslagers S, Graham J, Omar MM, Heer R, Gnanapragasam VJ, Robson CN, Leung HY. McKie AB, et al. Oncogene. 2005 Mar 24;24(13):2166-74. doi: 10.1038/sj.onc.1208371. Oncogene. 2005. PMID: 15735753

7

The use of acellular porcine collagen matrix to facilitate renal parenchymal closure during partial nephrectomy.

Douglas DA, Cross WR, Prescott S. Douglas DA, et al. BJU Int. 2005 Nov;96(7):1142-3. doi: 10.1111/j.1464-410X.2005.05814.x. BJU Int. 2005. PMID: 16225545 No abstract available.

8

Long QTc predicts future cardiac death in stroke survivors.

Wong KY, Mac Walter RS, Douglas D, Fraser HW, Ogston SA, Struthers AD. Wong KY, et al. Among authors: douglas d. Heart. 2003 Apr;89(4):377-81. doi: 10.1136/heart.89.4.377. Heart. 2003. PMID: 12639861 Free PMC article.

9

Normalising interdisciplinary role-based goal setting in inpatient brain injury rehabilitation: reflections and recommendations of clinicians.

Doig E, Prescott S, Pick V, Turner B, Suleman S, Douglas D, Foster M. Doig E, et al. Among authors: douglas d. Disabil Rehabil. 2023 Feb;45(4):673-683. doi: 10.1080/09638288.2022.2040612. Epub 2022 Mar 12. Disabil Rehabil. 2023. PMID: 35282717

10

Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes.

Kilkenny MF, Phan HT, Lindley RI, Kim J, Lopez D, Dalli LL, Grimley R, Sundararajan V, Thrift AG, Andrew NE, Donnan GA, Cadilhac DA; Stroke123 Investigators and the AuSCR Consortium. Kilkenny MF, et al. Stroke. 2021 Aug;52(9):2874-2881. doi: 10.1161/STROKEAHA.120.033648. Epub 2021 Jun 17. Stroke. 2021. PMID: 34134509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters